Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +3.32% | +0.72% | +12.00% |
02/05 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.00% | 528M | |
-2.49% | 88.14B | |
+1.45% | 40.44B | |
-14.43% | 32.24B | |
+51.20% | 24.39B | |
-14.85% | 15.59B | |
-13.87% | 12.14B | |
-7.87% | 12.18B | |
-39.40% | 12.3B | |
+5.62% | 8.87B |
- Stock Market
- Equities
- ABUS Stock
- News Arbutus Biopharma Corporation
- Arbutus Biopharma : Partners With Vaccitech for Phase 2a Trial of Potential Chronic Hepatitis B Virus Infection Therapies